Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about a Trump order to boost U.S. drug making, a key FDA departure, and more
President Trump signed an order designed to lower regulatory hurdles and make it faster for drug companies to manufacture products in the U.S.